Today, the screeners at HealthTechMovers.com picked up 3 HealthTech Stocks up over 88% past 10 days and have been added to our watchlist. These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.
MarketSectorMovers.com is also looking into these tickers DAWN, COGT, RMD, BSX, RACE, RTX and more.
One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
Summary: Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus.
Recent CRBP Stock Price (approx 10:00am EST.): $7.70
Previous Close for CRBP Stock: $7.45
Percentage Price Change Past 10 Days for CRBP stock: +143%
TipRanks.com reports that Corbus Pharmaceuticals stock currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating for CRBP stock with an average price target is $3.00.
Click here to get the full story on CRBP stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Pyxis Oncology Inc. is a preclinical oncology company. It focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers. The company's product pipeline includes antibody drug conjugate and monoclonal antibody. Pyxis Oncology Inc. is based in CAMBRIDGE, Mass.
Recent PYXS Stock Price (approx 10:00am EST.): $4.02
Previous Close for PYXS Stock: $3.85
Percentage Price Change Past 10 Days for PYXS stock: +93%
TipRanks.com reports that Pyxis Oncology stock currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating for PYXS stock with an average price target is $12.50.
Click here to get the full story on PYXS stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Tiziana Life Sciences PLC is a biotechnology company. It focuses on the clinical development for the treatment of cancers, chronic inflammatory and autoimmune neurodegenerative disorders. The company's product pipeline consists of Foralumab TZLS-401 and Milciclib TZLS-201 which are in clinical stage. Tiziana Life Sciences PLC is based in London, United Kingdom.
Recent TLSA Stock Price (approx 10:00am EST.): $1.11
Previous Close for TLSA Stock: $1.07
Percentage Price Change Past 10 Days for TLSA stock: +88%
Click here to get the full story on TLSA stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Just a reminder, one resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
The other great tool for charting is TradingView.com, so you might want to check that out too.
The information in this article was pulled from third part services. The prices listed above are not real-time and will be delayed at least 15 minutes.
MarketSectorMovers.com keeps investors informed of the top moving stocks within each sector including Health & Biotech, Technology, Energy, Metals & Mining, Financial, Consumer, Communication Services and more. We provide investors with timely information regarding top moving stocks that is sourced from our proprietary stocks screens, partner stock analysts and breaking news that identify and monitor stocks that are on the move. Join thousands of investors who already signed up for our free subscription to MarketSectorMovers.com.
